Malignancy progression and treatment efficacy estimation of osteosarcoma patients based on in vitro cell culture model and analysis
Background: Osteosarcoma (OS) usually happens in patients under 20 years old and is notorious for its low survivorship and limb loss. Personalized medicine is a viable approach to increase the efficiency of chemotherapy which is the main prognostic factor for survivorship after surgical treatment. M...
Saved in:
| Main Authors: | Hsi-Chieh Lin, Kuei-Hsiang Hsu, Jir-You Wang, Wei-Ming Chen, Yi-Chung Tung, Yu-Ping Su |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Journal of the Formosan Medical Association |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664624003073 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early Development of Acute Myeloid Leukemia Following Treatment of Osteosarcoma: A Case Report and Review of the Literature
by: Yu-Mei Shen, et al.
Published: (2009-10-01) -
The Efficacy and Safety of Pegylated Liposomal Doxorubicin‐Based Neoadjuvant Chemotherapy in Children With Osteosarcoma: A Retrospective Real‐World Study
by: Guoqi Wang, et al.
Published: (2025-04-01) -
Calcium Phosphate Loaded with Curcumin Prodrug and Selenium Is Bifunctional in Osteosarcoma Treatments
by: Mingjie Wang, et al.
Published: (2024-11-01) -
An analysis of extraskeletal osteosarcoma based on the literature
by: De-Hui Wang, et al.
Published: (2025-01-01) -
Clinical Outcome Following Prolonged Neoadjuvant Chemotherapy and Delayed Surgery in Osteosarcoma Patients: An Evidence-based Clinical Review
by: Waluyo Sugito, et al.
Published: (2022-04-01)